
Jorge Omar Yanez-Cuna
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Jorge Omar Yanez-Cuna
- Current 1 year and 2 months, since Apr 2025
Consultant
Stealth Biotech
- Current 4 years and 7 months, since Nov 2021
Associated Director / Head of R&D
Anjarium Biosciences AG
Led R&D for a rapidly evolving biotech developing non-viral gene delivery and novel DNA technologies. The latter became the core value driver behind its acquisition by National Resilience. I left the company following the relocation of the technology and operations to the USA. - Identified poor translation between in vitro, in vivo models as a critical blocker and designed a multi-omics pipeline to screen 20–40 LNP formulations directly in NHPs. - Built a multidisciplinary team of 10+ scientists.
- 2 years and 10 months, Jan 2019 - Oct 2021
Principal Scientist
Asklepios BioPharmaceutical Inc (AskBio)
Senior scientific role within a pioneering gene therapy (rAAV) company. Directly contributed to two indications now in clinical trials and to AskBio’s acquisition by Bayer for $2Bn. - Led the design and development of AAV regulatory elements using AI/ML, bioinformatics and multi-omics to support multiple programmes. - Owned preclinical design and execution for muscle and cardiac gene therapies, with additional contributions to liver and CNS programmes.
- 1 year and 9 months, Apr 2017 - Dec 2018
Senior Research Scientist
Synpromics LTD
Joined a growing biotech to build the scientific pipeline underpinning its gene therapy partnerships and commercial strategy. The platform formed the scientific foundation for Synpromics’ acquisition by AskBio. - Built the core scientific pipeline integrating AI/ML, multi-omics and preclinical validation to design synthetic promoters for gene therapy. - Delivered nine client programmes across multiple tissues, maintaining alignment with partners such as BioMarin, AGTC, and Solid Biosciences.
- 2 years and 9 months, Jul 2014 - Mar 2017
Postdoctoral Researcher
Netherlands Cancer Institute (NKI)
Working with Bas van Steensel, focusing on gene regulation and multi-omics technology development in a world-class cancer research institute. - Established high-throughput multi-omics screening assays using CRISPR-based and transposon technologies. - Published multiple peer-reviewed papers, including work in Cell, advancing understanding of chromatin organisation.
- 5 years, May 2009 - Apr 2014
PhD Candidate
Research Institute of Molecular Pathology (IMP)
Working with Alexander Stark, pioneered early applications of AI/ML to decode gene regulation using multi-omics data, contributing to the development of STARR-seq and publishing in Nature. - Awarded VBC PhD Award for Outstanding Thesis.
Sprachen
Spanish
C2 (Verhandlungssicher / Muttersprachlich)
English
C1 (Fließend)
French
B1-B2 (Gute Kenntnisse)
German
B1-B2 (Gute Kenntnisse)
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
21 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.
